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Because bacteriostatic concentrations of vancomycin are effective in prophylaxis
against endocarditis due to Streptococcus sanguis in rats, the efficacy of three other
bacteriostatic antibiotics was investigated against three different streptococcal species
that cause subacute endocarditis in humans: Streptococcus intermedius, S. sanguis, and
Streptococcus mitior. Rats were challenged by intravenous injection of 2 x lOs colony-
forming units of streptococci 24 hr after intracardiac insertion of a transaortic catheter
and 30 min after intravenous injection of various doses of clindamycin, erythromycin,
and doxycycline. Significant protection was achieved with all three antibiotics, but only
clindamycin was fully effective against all three species at doses that simulated serum
levels achievable in humans after oral administration. Endocarditis was prevented by
antibiotic concentrations in serum far below minimal bactericidal concentrations for
these streptococci. Furthermore, serum at the time of bacterial challenge was not
bactericidal. Therefore, single doses of nonbactericidal antibiotics prevented endocar-
ditis in rats by mechanisms other than bacterial killing.
Recommendations for antibiotic prophylaxis
against bacterial endocarditis require the adminis-
tration of multiple high doses of bactericidal anti-
biotics and parenteral administration for high-risk
patients [I]. These recommendations are based
largely on studies in rabbits and have presented a
number of practical problems. Prolonged or par-
enteral administration of prophylactic antibiotics
is far more expensive and less acceptable to both
patients and their dentists than a single oral dose.
Poor compliance may jeopardize the effectiveness
of regimens involving multiple or parenteral doses
[2]. There are also important limitations in the ex-
perimental data on which the recommendations
for prophylaxis during dental procedures are based.
The experimental studies involved only rabbits
and a single strain of Streptococcus sanguis [3, 4].
Moreover, failure of certain antibiotic regimens in
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the rabbit model could be due to the number of
microorganisms used to induce infection, which
greatly exceeded that found in humans after den-
tal manipulation [2]. These problems as well as
possible failures with the presently recommended
regimens in humans [5] have prompted us to con-
tinue experimental studies of the prevention of
bacterial endocarditis.
Recent experiments with vancomycin in rats [6]
and rabbits [7] introduced the possibility of
mechanisms other than bacterial killing operating
in the prevention of endocarditis. Therefore, the
present study was undertaken to test three nonbac-
tericidal antibiotics (erythromycin, clindamycin,
and doxycycline), against three species of viridans
streptococci that are responsible for infective en-
docarditis.
Materials and Methods
Microorganisms. Two previously described
species of a-hemolytic streptococci were used,
Streptococcus intermedius (described elsewhere as
S. sanguis [6]) and S. sanguis biotype II (provided
by Dr. D. T. Durack, Duke University Medical
Center, Durham, N.C. [3, 4]), as well as a strain
of Streptococcus mitior that was also isolated
from a patient with bacterial endocarditis. MICs
and MBCs of clindamycin (Upjohn Co., Kalama-
zoo, Mich.), erythromycin (Eli Lilly and Co., In-
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dianapolis), and doxycycline (Pfizer, Zurich) were
determined by broth dilution tests, using Mueller-
Hinton broth (Difco Laboratories, Detroit) and 5
x lOs microorganisms as the inoculum. Special
care was taken to avoid the carry-over of antibiot-
ics [8]. The MBC was defined as the lowest con-
centration of antibiotic that produced 99.9070 kill-
ing after 24 hr of incubation.
Antibiotic serum levels and serum bactericidal
activity. Serum levels of antibiotics were deter-
mined in five rats at each time point by the agar
diffusion technique [9]. The serum bactericidal ac-
tivity of antibiotics against the three streptococci
was determined by standard methods [10] 30 min
after iv injection of 50 mg of clindamycin or
erythromycin/kg of body weight or 10 mg of doxy-
cycline/kg. The serum bactericidal activity was de-
fined as the highest serum dilution that provided
99.9% killing after 24 hr of incubation.
Production and prophylaxis of endocarditis.
Sterile vegetations were produced in female Wistar
rats (weight, 180-200 g) by a modification of a
previously described method [6]. In brief, a poly-
ethylene catheter (model no. PP 10; Portex, Hythe,
Kent, England) was passed through the aortic
valve via the right carotid artery and secured with
a silk ligature. Twenty-four hours after catheteri-
zation, rats were injected in the tail vein with 0.5
ml of various concentrations of antibiotics or
0.85% NaC!. Thirty minutes later 0.5 ml of saline
contammg lOS cfu of bacteria, the minimal in-
oculum needed to produce endocarditis in >80070
of control rats, was injected iv. Rats were killed
48-72 hr after bacterial challenge, and aortic
vegetations were excised, weighed, homogenized
in 1 ml of 0.85% NaCI, serially diluted, and
plated. Colony counts were done after 48 hr of in-
cubation at 37 C. This method permitted the de-
tection of 5 x 102 cfu/g of vegetation.
Statistical analysis. The X2 test with Yates's
correction and Student's t-test (unpaired) were used
for statistical comparisons.
Results
Antibiotic sensitivity, antibiotic serum levels,
and serum bactericidal activity. All three strep-
tococcal species had very low MICs for the three
antibiotics tested (figure 1), but MBCs were large-
ly above achievable serum levels (figure 2). At the
time of bacterial challenge, serum bactericidal ac-
tivity against all three streptococcal species was
undetectable with any of the three antibiotics.
Prophylaxis of endocarditis with clindamycin.
Despite the lack of bacterial killing in vitro, clin-
damycin at doses of 50 and 20 mg/kg achieved
very efficient prophylaxis against the three strep-
tococci tested (figure 1). The 20 mg/kg dose pro-
duced peak serum levels below the 4.5 Ilg/ml
achieved in humans after an oral dose of 450 mg
34
CLiNDAMYCIN
25 34 C26
to
t
La~ t~ La* 10~
C '0 C '0 C 10 mgikg
*EJ
C 10 mg;kg
*
.r
LlJ
34
C 20 10
74
.~
-.
C 502010
86
ERYTHROMYCIN DOXYCYCLINE
S. INTERMEDIUS S. SANGUIS S.MITIOR S.INTEAMEDtUS S.SANGUtS S. MITIOR
MIC:Q032 MIC:Q016 MIC:Q032 MIC-025 MIC 0.063 MIC 0032
WBC,>128 MBC:>l28 MBC:128 MBC >126 MBC 16 MBC >128
6.4 5,35.7 !li]]] ~ 159 6°1 ~_Ji] Lag lO~~g14 1.31.1 1. 2.4 to 1,4 12 1.6
**~
c 20 10 mgjkgC 20 10
~ru
74
s. SANGUIS S. MITIOR
MIC:<QOO2 MIC;O.016
MBC:>64 PJBC: 64
S.INTERMEDIUS
MIC:Q032
MBC> 64
L09-Jo~~W I~: 3.3 6.0 t~1
00
~,
~ 92
15 :,a:" ~8ili 4Jl!5~ Ji!lo 01;:; **19 15
C 50 20 10
Figure 1. Incidence of endocarditis due to Streptococcus intermedius, Streptococcus sanguis, and Streptococcus
mitiorafter prophylaxis with various doses of clindamycin, erythromycin, and doxycycline administered iv 30 min be-
fore bacterial challenge. Numbers within the bars indicate the total number of rats in the groups; numbers beneath the
bars indicate the doses (mg/kg of body weight) of the prophylactic antibiotics. Results for control rats (C) that were
injected iv with 0.85070 NaCI are shown. Above the bars the log of the mean (± sn) bacterial density (MBD) recovered
from infected vegetation in each group are shown in boxes. The MICs and MBCs for the antibiotics are also indi-
cated. Statistical comparisons are as follows: (*) indicates P< 0.01 in comparison with controls; (t) indicates P< 0.05
in comparison with controls.
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Figure 2. Serum levels of clindamycin, erythromycin, and doxycycline0.5,2, and 4 hr after single iv injections in
rats. Dotted lines represent peak levels achieved in humans after oral doses of 450 mg of clindamycin, 500 mg of
erythromycin, and 200 mg of doxycycline [11].
[11] (figure 2). The 10 mg/kg dose was not uni-
formly effective.
Prophylaxis of endocarditis with erythromycin.
Although the MICs and MBCs of erythromycin
for the three streptococcal species were similar to
those of clindamycin, erythromycin was less ef-
ficient than clindamycin in preventing endocar-
ditis. With the dose of 10 mg/kg, which produced
peak serum levels similar to the 0.5-2.0 IAg/ml
achieved in humans after an oral dose of 500 mg
[11] (figure 2), only endocarditis due to S. sanguis
and S. mitior was significantly prevented. The in-
cidence of infection with S. sanguis was "'30070.
Prophylaxis of endocarditis with doxycycline.
Although half of that in controls, the incidence of
endocarditis due to S. intermedius and S. sanguis
in doxycycline-treated rats was still >40% with the
dose of 10 mg/kg. This dose produced peak serum
levels similar to the 2.8 IAg/ml achieved in humans
after an oral dose of 200 mg [11] (figure 2).
Quantitative cultures of infected vegetations.
For all three streptococcal species, the number of
bacterialg of infected vegetations was similar in
control rats to that in rats in which prophylaxis
failed (figure 1).
Discussion
Previous studies in rabbits that had been used to
establish current recommendations for the pro-
phylaxis against bacterial endocarditis [1] sug-
gested that bacterial killing is the mechanism re-
sponsible for successfulprotection. This conclusion
was based on two observations. (1) There seemed
to be a correlation between the efficacy of antibi-
otics or combinations of synergistic antibiotics in
killing bacteria in vitro and the protection obtained
in vivo [3]. (2) Bacteriostatic antibiotics such as
tetracycline failed to protect from infection [12].
These results served as a basis for the current
American Heart Association recommendations of
high doses and prolonged administration of bacte-
ricidal antibiotics for prophylaxis of endocarditis
in humans [1]. However, these experiments in rab-
bits involved extremely large bacterial inocula. Re-
cent experiments from two different laboratories
using inocula that are 2 to 3 log smaller and a
single dose of vancomycin as the prophylactic an-
tibiotic have shown that experimental endocarditis
can be prevented in the absence of bacterial killing
[6, 7]. Even this smaller inoculum provides a strin-
gent test of antibiotic prophylaxis because the re-
sulting bacteremia is far greater than that ob-
served in humans after oral procedures [2] and
produces 80%-100% endocarditis in animals. The
rats [6], like high-risk human patients, have a per-
manent intracardiac foreign body. Therefore, it
was of interest to use this model to reexamine the
efficacy of single doses of orally absorbable, non-
bactericidal antibiotics.
Previous attempts to protect rabbits with clin-
damycin at doses of 10mg/kg against high inocula
(l08 cfu) of S. sanguis failed [4]. In the present
study, we found that this same dose produced sim-
ilar peak concentrations in rats and often failed to
protect against smaller inocula (l05 cfu) of-three
streptococcal species. In contrast, excellent pro-
tection was afforded by doubling the dose (20
mg/kg). This protection was achieved by clin-
damycin levels below those which follow a single
450-mg oral dose in humans. Thus, peak serum
levels conveniently achievable in patients pro-
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tected rats from three streptococcal species which
colonize the mouth and cause endocarditis in
humans. Furthermore, rats were protected at clin-
damycin levels below the MBCs for these strep-
tococci and in the absence of serum bactericidal
activity.
Erythromycin protected rats from endocarditis
due to S. sanguis and S. mitior at doses resulting
in serum levels achievable in humans after an oral
dose of 500 mg. Against both S. intermedius in the
present experiments and S. sanguis in rabbits [4],
erythromycin was protective only at doses that re-
sulted in serum levels far above those obtained in
humans after oral administration of 500 mg of the
drug [11]. Like tetracycline hydrochloride in rab-
bits [12], doxycycline failed to provide sufficient
protection in rats against infection with two of the
three species tested. Thus, both erythromycin and
doxycycline protected rats against only some
streptococcal species at doses usually given orally
to patients. As with clindamycin, protection was
achieved in the absence of serum bactericidal
activity.
Since sublethal concentrations of vancomycin in
previous studies [6, 7] and three bacteriostatic an-
tibiotics in the present experiments provide protec-
tion against endocarditis, mechanisms other than
killing must be involved. We investigated in two
ways the possibility that bacteriostatic antibiotics
might have merely delayed the growth of bacteria
in vegetations. (1) We compared the numbers of
streptococci in vegetations from infected controls
and from animals infected in spite of prophylaxis.
If antibiotics suppressed rather than prevented in-
fection, rats in which prophylaxis failed should
have fewer organisms in their vegetations than un-
treated control animals. In fact, we found the
same high numbers in both groups of rats (figure
1). (2) We examined animals one week rather than
three days after challenge (data not shown) and
found no increase in the percentage of animals in
which prophylaxis failed. We conclude that
bacteriostatic antibiotics prevented, not just sup-
pressed, infection - that is, prophylaxis was an all-
or-none phenomenon.
Another possible mechanism is suggested from
previous experiments with vancomycin. In both
rats and rabbits, vancomycin appears to protect
by inhibiting adherence of streptococci to sterile
vegetations [6, 7]. This interpretation is supported
by demonstration in vitro that nonbactericidal
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concentrations of vancomycin and penicillin pre-
vent adherence of streptococci to platelet-fibrin
clots [7, 13]. MICs of clindamycin have similar
negative effects on the adherence of Escherichia
coli [14] and alter surface structures of strepto-
cocci that mediate adherence [15, 16]. These
observations raise the possibility that one mecha-
nism by which clindamycin or other bacteriostatic
antibiotics prevented endocarditis is interference
with adherence.
Regardless of the mechanism responsible for
protection, the present experiments suggest that
the use of stringent antibiotic regimens aimed at
killing bacteria might not be required for adequate
prevention of bacterial endocarditis in humans.
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